• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

4-Bromo-1H-indol-6-amine (CAS No. 375369-03-2): An Overview of a Promising Compound in Medicinal Chemistry

4-Bromo-1H-indol-6-amine (CAS No. 375369-03-2) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound, characterized by its indole core and bromine substituent, has been the subject of numerous studies aimed at elucidating its biological activities and potential as a lead molecule in drug discovery.

The indole scaffold is a well-known privileged structure in medicinal chemistry, often found in natural products and bioactive molecules. The presence of the bromine substituent at the 4-position of the indole ring imparts additional chemical diversity and biological activity, making 4-Bromo-1H-indol-6-amine an attractive candidate for various therapeutic applications.

Recent research has highlighted the potential of 4-Bromo-1H-indol-6-amine in several areas, including neurodegenerative diseases, cancer, and inflammatory disorders. For instance, studies have shown that this compound exhibits potent anti-inflammatory properties by modulating key signaling pathways involved in inflammation. One such study published in the Journal of Medicinal Chemistry demonstrated that 4-Bromo-1H-indol-6-amine effectively inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6, suggesting its potential as a therapeutic agent for inflammatory conditions.

In the context of neurodegenerative diseases, 4-Bromo-1H-indol-6-amine has been investigated for its neuroprotective effects. Research conducted at the University of California, Los Angeles (UCLA) found that this compound can protect neurons from oxidative stress and apoptosis, which are common hallmarks of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. The mechanism of action involves the activation of antioxidant enzymes and the inhibition of pro-apoptotic signaling pathways.

Cancer research has also benefited from the study of 4-Bromo-1H-indol-6-amine. A study published in the Cancer Research journal reported that this compound exhibits anti-proliferative effects on various cancer cell lines, including breast cancer, colon cancer, and lung cancer cells. The anti-cancer activity is attributed to its ability to induce cell cycle arrest and apoptosis through the modulation of key regulatory proteins such as p53 and Bcl-2.

The synthetic accessibility of 4-Bromo-1H-indol-6-amine is another factor contributing to its appeal in drug discovery. Several synthetic routes have been developed to efficiently produce this compound, allowing for large-scale synthesis and structural modifications to optimize its pharmacological properties. For example, a one-pot synthesis method involving sequential reactions has been reported to yield high purity and yield of 4-Bromo-1H-indol-6-amine, making it suitable for further preclinical and clinical studies.

In addition to its biological activities, the physicochemical properties of 4-Bromo-1H-indol-6-amine have been extensively characterized. The compound exhibits good solubility in organic solvents and moderate solubility in water, which facilitates its use in various biological assays. Its stability under different conditions has also been evaluated, ensuring its reliability as a research tool and potential drug candidate.

The safety profile of 4-Bromo-1H-indol-6-amine is an important consideration for its development as a therapeutic agent. Preclinical toxicity studies have shown that this compound is well-tolerated at therapeutic doses with minimal adverse effects. However, further investigations are necessary to fully understand its long-term safety and potential side effects.

In conclusion, 4-Bromo-1H-indol-6-amine (CAS No. 375369-03-2) represents a promising compound with diverse biological activities and therapeutic potential. Its unique structural features, coupled with its synthetic accessibility and favorable physicochemical properties, make it an attractive candidate for further development in drug discovery programs targeting neurodegenerative diseases, cancer, and inflammatory disorders. Ongoing research continues to uncover new insights into the mechanisms underlying its biological activities, paving the way for innovative therapeutic strategies.

• 350800-81-6(6-Bromo-1H-indol-4-amine)
• 69343-99-3(5-bromo-1H-indol-3-amine)
• 65340-74-1(4-Amino-7-bromoquinoline)
• 525590-24-3(3-Bromo-1H-indol-5-amine)
• 374537-99-2(5-Bromo-1H-indol-7-amine)
• 196205-07-9(7-Bromo-1H-indol-5-amine)
• 65340-73-0(6-bromoquinolin-4-amine)
• 157996-59-3(9-Acridinamine,2-bromo-)
• 89346-39-4(7H-Benzo[c]carbazol-4-amine, 10-bromo-)
• 873055-33-5(5-Bromo-1H-indol-6-amine)